The new RABTA (Random Access Biochip Technology Analyser) sets a high standard in laboratory diagnostics by combining advanced biochip technology with exceptional efficiency. Designed for seamless operation, the RABTA platform allows uninterrupted workflows and increased productivity. With rapid random-access capabilities, the analyser provides precise and reliable results across a wide range of assays.
Featuring five intuitive modules, this innovative analyser simplifies high-throughput biological analysis, enabling clinicians to conduct complex assays quickly and accurately. Each module is tailored for specific functions, ensuring easy integration and adaptability for various applications, from diagnostics to advanced research. Its random-access capability allows simultaneous processing of multiple samples, making it an essential tool for modern laboratories.
High Throughput
A maximum throughput of up to 60 samples can be loaded per hour, providing up to 2,640 test results per hour / 19,580 test results per day.
2.5 Hour Walk Away
A fully automated platform with an operator walkaway time of up to 2.5 hours. A single operator is all that’s required to run the RABTA.
Priority Sampling
Software allows users to assign samples as a priority over others so that priority samples can be run and results reported rapidly, eliminating the constraints of batch testing.
Zero Carry-Over Risk
With aspiration abilities from 1.5µl upward, the RABTA does not need pre-dilution. The system utilises single-use tips for aspiration and dispense, meaning there is no carry-over risk at all, ensuring high accuracy with every result.
Workflow Consolidation
The RABTA consolidates the workflow of multiple laboratories into a single analyser. The workload of laboratory staff is minimised, as only consumables and samples need to be loaded, and tests are selected via onscreen software.
Module Access
Continuous access to samples. Software-controlled access to reagents, biochips, signal and waste. The system can hold up to 60 samples with continuous access, and 120 biochips with software-controlled access.
Multiplex Testing
Simultaneous detection of up to 44 targets from a single patient sample through our patented Biochip Array Technology.
Rapid Results
Software intuitively analyses what tests are being run and assigns the order of samples in the most time-efficient way for analysing and reporting results. The time to first sample results is just 36 minutes, with up to 44 results per sample. Results for remaining samples are released 1 sample per minute onward.
Rapid Start Up
The system will be ready for use in under 15 minutes when started from a standby state.
Randox Biochip Array Technology is an innovative multiplex testing platform that allows for the simultaneous detection of multiple analytes from a single sample. This technology is based on a remarkable 9x9mm biochip, which functions as a solid-phase reaction vessel. Each biochip is pre-coated with an array of discrete test regions (DTRs), enabling the detection of up to 48 different tests from one sample.
Using competitive chemiluminescent immunoassays when a sample is applied to the biochip, specific reactions occur at each DTR, producing light signals. These signals are detected and analysed using sophisticated digital imaging technology revealing the concentration of each analyte with pinpoint accuracy.
By consolidating multiple assays onto one biochip, the Biochip Array reduces the time and resources needed for diagnostics, making it an indispensable tool for modern diagnostics. This efficiency has transformed how laboratories are analysing samples, processing a higher volume without compromising speed or accuracy.

To find out more about the Evidence Rabta or to discuss arranging a demo, enquire now.